Karyopharm Therapeutics Inc. Quarterly Return On Assets in % from Q4 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q4 2014 to Q3 2024.
  • Karyopharm Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -41.3 %, a 7.66% increase year-over-year.
  • Karyopharm Therapeutics Inc. annual Return On Assets for 2023 was -50.5 %, a 13% increase from 2022.
  • Karyopharm Therapeutics Inc. annual Return On Assets for 2022 was -58 %, a 31% decline from 2021.
  • Karyopharm Therapeutics Inc. annual Return On Assets for 2021 was -44.3 %, a 18.4% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -41.3 +3.42 +7.66% Jul 1, 2024 Sep 30, 2024
Q2 2024 -38.7 +7.97 +17.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -57.8 -3.86 -7.16% Jan 1, 2024 Mar 31, 2024
Q4 2023 -50.5 +7.53 +13% Oct 1, 2023 Dec 31, 2023
Q3 2023 -44.7 -12.3 -37.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -46.7 -9.37 -25.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -54 -16 -42.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -58 -13.7 -31% Oct 1, 2022 Dec 31, 2022
Q3 2022 -32.4 +40.7 +55.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -37.3 +31.3 +45.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -37.9 +23.6 +38.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -44.3 +9.98 +18.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -73.1 -16.7 -29.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -68.6 -14.1 -25.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -61.5 -1.73 -2.89% Jan 1, 2021 Mar 31, 2021
Q4 2020 -54.3 +17.1 +24% Oct 1, 2020 Dec 31, 2020
Q3 2020 -56.4 +15.4 +21.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -54.5 +24.9 +31.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -59.8 +14.8 +19.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -71.4 +2.61 +3.53% Oct 1, 2019 Dec 31, 2019
Q3 2019 -71.9 +7.44 +9.38% Jul 1, 2019 Sep 30, 2019
Q2 2019 -79.5 -3.55 -4.68% Apr 1, 2019 Jun 30, 2019
Q1 2019 -74.6 +6.74 +8.29% Jan 1, 2019 Mar 31, 2019
Q4 2018 -74 +1.27 +1.69% Oct 1, 2018 Dec 31, 2018
Q3 2018 -79.3 -11.1 -16.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -75.9 -12.6 -19.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -81.4 -16.2 -24.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -75.3 -15 -24.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 -68.2 -9.6 -16.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -63.3 -6.12 -10.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -65.2 -12.6 -24.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -60.3 -13.4 -28.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -58.6 -13.2 -29% Jul 1, 2016 Sep 30, 2016
Q2 2016 -57.2 -15.9 -38.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -52.5 -12.7 -31.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -46.9 -6.08 -14.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -45.5 Jul 1, 2015 Sep 30, 2015
Q2 2015 -41.3 Apr 1, 2015 Jun 30, 2015
Q1 2015 -39.8 Jan 1, 2015 Mar 31, 2015
Q4 2014 -40.8 Oct 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.